United States · FDA National Drug Code directory
Cladribine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62049-286_8a24939c-6118-83ad-5a85-5277500bb20a
- Product NDC
- 62049-286
- Form
- TABLET
- Composition / generic term
- Cladribine
- Labeler
- Genvion Corporation
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251125
- Source listing expiry
- 20261231
Source-listed ingredients
- CLADRIBINE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 TABLET in 1 CARTON (62049-286-04) · 62049-286-04
- 5 TABLET in 1 CARTON (62049-286-05) · 62049-286-05
- 6 TABLET in 1 CARTON (62049-286-06) · 62049-286-06
- 7 TABLET in 1 CARTON (62049-286-07) · 62049-286-07
- 8 TABLET in 1 CARTON (62049-286-08) · 62049-286-08
- 9 TABLET in 1 CARTON (62049-286-09) · 62049-286-09
- 10 TABLET in 1 CARTON (62049-286-10) · 62049-286-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →